Ivan Domicio da Silva Souza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ivan Domicio da Silva Souza has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra M. Maldonado López
Good Molecules, LLC
6 shared publications - Jacqueline Nelisis Zanoni
State University of Maringá
5 shared publications Aiden Curry
Affiliation Good Molecules, LLC, Philadelphia, Pennsylvania, United States of America
2 shared publicationsKylie Q. Sahloff
Affiliation Good Molecules, LLC, Philadelphia, Pennsylvania, United States of America
2 shared publicationsVania Passarini Takahashi
2 shared publications- Vania Passarini Takahashi
Postgraduate Studies Section, Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. do Café S/N, Ribeirão Preto, SP, 14040-903, Brazil
2 shared publications
Latest Publications
- Open Access
- 20 October 2026
- Published by Taylor & Francis in Cutaneous and Ocular Toxicology
- p. 1-9
Randomized, double-blinded, placebo-controlled clinical safety evaluation of a facial brightening toner containing niacinamide and β-arbutin used with 4% hydroquinone
Melanogenesis serves as a primary defense mechanism that protects skin cells from ultraviolet (UV) damage by absorbing light through melanin production [1]. This process involves enzymes such as ty...
- 20 October 2026
- Published by Taylor & Francis in Cutaneous and Ocular Toxicology
- p. 1-9
Open AccessRandomized, double-blinded, placebo-controlled clinical safety evaluation of a facial brightening toner containing niacinamide and β-arbutin used with 4% hydroquinone
Melanogenesis serves as a primary defense mechanism that protects skin cells from ultraviolet (UV) damage by absorbing light through melanin production [1]. This process involves enzymes such as ty...
- Open Access
Hurdles in Melasma Management: An AI-Assisted Review of Placebo- and Hydroquinone-Controlled Clinical Studies (2014–2024)
Melasma is a chronic hyperpigmentation disorder that significantly impacts quality of life. Given the persistent challenges in melasma management, there is a need to evaluate therapies that may offer long-term treatment. This descriptive review analyzes interventional clinical studies involving melasma patients and placebo or hydroquinone (HQ) comparators published between 2014 and 2024. Two human authors screened studies and extracted data, with artificial intelligence used as a human-supervised support tool for screening assistance, data extraction, and discussion synthesis. Study limitations were evaluated descriptively. Treatments were grouped into five categories: HQ-based Standard Treatments, Isolated Molecules as Depigmenting Therapies, Botanical and Antioxidant-Based Therapies, Regenerative and Microenvironment-Modulating Therapies, and Procedure-Assisted and Combination Treatments. HQ remained a key benchmark, although recurrence and tolerability limitations were frequently observed. Several non-HQ or adjunctive approaches demonstrated benefit when administered orally, topically, intradermally, or via iontophoresis. Botanical antioxidants, synbiotics, epidermal growth factor, and platelet-rich plasma also showed promising efficacy. Nevertheless, the evidence base was constrained by small sample sizes, heterogeneous comparators, inconsistent endpoints, mixed objective and subjective assessments, and variable follow-up durations, which prevented meta-analysis. Research on melasma treatment is growing worldwide, with several promising non-HQ and adjunctive strategies emerging. However, standardization of outcomes, comparator selection, and longer follow-up periods is needed to clarify efficacy, tolerability, and relapse prevention throughout diverse skin tones.
Open AccessHurdles in Melasma Management: An AI-Assisted Review of Placebo- and Hydroquinone-Controlled Clinical Studies (2014–2024)
Melasma is a chronic hyperpigmentation disorder that significantly impacts quality of life. Given the persistent challenges in melasma management, there is a need to evaluate therapies that may offer long-term treatment. This descriptive review analyzes interventional clinical studies involving melasma patients and placebo or hydroquinone (HQ) comparators published between 2014 and 2024. Two human authors screened studies and extracted data, with artificial intelligence used as a human-supervised support tool for screening assistance, data extraction, and discussion synthesis. Study limitations were evaluated descriptively. Treatments were grouped into five categories: HQ-based Standard Treatments, Isolated Molecules as Depigmenting Therapies, Botanical and Antioxidant-Based Therapies, Regenerative and Microenvironment-Modulating Therapies, and Procedure-Assisted and Combination Treatments. HQ remained a key benchmark, although recurrence and tolerability limitations were frequently observed. Several non-HQ or adjunctive approaches demonstrated benefit when administered orally, topically, intradermally, or via iontophoresis. Botanical antioxidants, synbiotics, epidermal growth factor, and platelet-rich plasma also showed promising efficacy. Nevertheless, the evidence base was constrained by small sample sizes, heterogeneous comparators, inconsistent endpoints, mixed objective and subjective assessments, and variable follow-up durations, which prevented meta-analysis. Research on melasma treatment is growing worldwide, with several promising non-HQ and adjunctive strategies emerging. However, standardization of outcomes, comparator selection, and longer follow-up periods is needed to clarify efficacy, tolerability, and relapse prevention throughout diverse skin tones.
- Open Access
- 15 May 2026
- Published by MDPI AG in Preprints.org
Hurdles in Melasma Management: An AI-Assisted Review of Placebo- and Hydroquinone-Controlled Clinical Studies (2014–2024)
Melasma is a chronic hyperpigmentation disorder that significantly impacts quality of life. Given the persistent challenges in melasma management, there is a need to evaluate therapies that may offer long-term treatment. This review analyzes placebo- and hydroquinone (HQ)-controlled interventional studies of melasma published between January 1, 2014, and December 31, 2024. Screening, data extraction, and discussion synthesis were performed with artificial intelligence assistance under human oversight. Treatments were grouped into five categories: HQ-based Standard Treatments, Isolated Molecules as Depigmenting Therapies, Botanical and Antioxidant-Based Therapies, Regenerative and Microenvironment-Modulating Therapies, and Procedure-Assisted and Combination Treatments. HQ remained a key benchmark, although recurrence and tolerability limitations were frequently observed. Several non-HQ or adjunctive approaches demonstrated benefit when administered orally, topically, intradermally, or via iontophoresis. Botanical antioxidants, synbiotics, epidermal growth factor, and platelet-rich plasma also showed promising efficacy. Nevertheless, the evidence base was constrained by small sample sizes, heterogeneous comparators, inconsistent endpoints, mixed objective and subjective assessments, and variable follow-up durations, which prevented meta-analysis. Research on melasma treatment is growing worldwide, with several promising non-HQ and adjunctive strategies emerging. However, standardization of outcomes, comparator selection, and longer follow-up periods is needed to clarify efficacy, tolerability, and relapse prevention throughout diverse skin tones.
- 15 May 2026
- Published by MDPI AG in Preprints.org
Open AccessHurdles in Melasma Management: An AI-Assisted Review of Placebo- and Hydroquinone-Controlled Clinical Studies (2014–2024)
Melasma is a chronic hyperpigmentation disorder that significantly impacts quality of life. Given the persistent challenges in melasma management, there is a need to evaluate therapies that may offer long-term treatment. This review analyzes placebo- and hydroquinone (HQ)-controlled interventional studies of melasma published between January 1, 2014, and December 31, 2024. Screening, data extraction, and discussion synthesis were performed with artificial intelligence assistance under human oversight. Treatments were grouped into five categories: HQ-based Standard Treatments, Isolated Molecules as Depigmenting Therapies, Botanical and Antioxidant-Based Therapies, Regenerative and Microenvironment-Modulating Therapies, and Procedure-Assisted and Combination Treatments. HQ remained a key benchmark, although recurrence and tolerability limitations were frequently observed. Several non-HQ or adjunctive approaches demonstrated benefit when administered orally, topically, intradermally, or via iontophoresis. Botanical antioxidants, synbiotics, epidermal growth factor, and platelet-rich plasma also showed promising efficacy. Nevertheless, the evidence base was constrained by small sample sizes, heterogeneous comparators, inconsistent endpoints, mixed objective and subjective assessments, and variable follow-up durations, which prevented meta-analysis. Research on melasma treatment is growing worldwide, with several promising non-HQ and adjunctive strategies emerging. However, standardization of outcomes, comparator selection, and longer follow-up periods is needed to clarify efficacy, tolerability, and relapse prevention throughout diverse skin tones.
- Open Access
- 30 March 2026
- Published by Wiley in International Journal of Cosmetic Science
- Vol. 48 (5) , 1042-1054
A serum and cream moisturization regimen outperforms separate use in sustaining hydration, reducing TEWL , and balancing surface lipids over an 8‐h study
Skin hydration can be achieved through complementary mechanisms in skincare formulations. Humectants retain water, while emollients and occlusives reduce transepidermal water loss (TEWL) by reinforcing the epidermal barrier. Although consumers follow skincare routines, biophysical comparisons of single‐product use versus regimen use across parameters such as hydration, TEWL, and sebum content are limited. Our study measured these parameters in 123 volunteers randomized into four treatment groups: Facial Cleanser (FC) control, Hyaluronic Acid Serum (HAS) group, Moisturizing Cream (MC) group, and Routine comprising HAS followed by MC. Corneometry, TEWL, and sebumetry were measured at baseline, 30 min, and 8 h after treatment application. Corneometry results at 30 min showed that HAS, MC, and Routine increased hydration when compared with FC. At 8 h, only the Routine remained higher than FC. Additionally, TEWL decreased at 30 min for HAS, MC, and the Routine versus FC, whereas at 8 h, only HAS remained lower than FC. We measured sebumetry because skin surface lipids support the epidermal barrier and thus maintain water homeostasis. FC reduced sebum at 30 min due to sebum stripping. However, at 8 h, the Routine's sebum measurements stayed closest to baseline and were lower than HAS and MC individually. Apart from objective measurements, perceived hydration was assessed by a subjective questionnaire. Volunteers who applied the routine reported greater immediate and long‐lasting hydration than those who applied HAS or MC individually. These results suggest that layering the Routine improved hydration durability with barrier‐relevant water‐retention benefits over an 8‐h wear period.
- 30 March 2026
- Published by Wiley in International Journal of Cosmetic Science
- Vol. 48 (5) , 1042-1054
Open AccessA serum and cream moisturization regimen outperforms separate use in sustaining hydration, reducing TEWL , and balancing surface lipids over an 8‐h study
Skin hydration can be achieved through complementary mechanisms in skincare formulations. Humectants retain water, while emollients and occlusives reduce transepidermal water loss (TEWL) by reinforcing the epidermal barrier. Although consumers follow skincare routines, biophysical comparisons of single‐product use versus regimen use across parameters such as hydration, TEWL, and sebum content are limited. Our study measured these parameters in 123 volunteers randomized into four treatment groups: Facial Cleanser (FC) control, Hyaluronic Acid Serum (HAS) group, Moisturizing Cream (MC) group, and Routine comprising HAS followed by MC. Corneometry, TEWL, and sebumetry were measured at baseline, 30 min, and 8 h after treatment application. Corneometry results at 30 min showed that HAS, MC, and Routine increased hydration when compared with FC. At 8 h, only the Routine remained higher than FC. Additionally, TEWL decreased at 30 min for HAS, MC, and the Routine versus FC, whereas at 8 h, only HAS remained lower than FC. We measured sebumetry because skin surface lipids support the epidermal barrier and thus maintain water homeostasis. FC reduced sebum at 30 min due to sebum stripping. However, at 8 h, the Routine's sebum measurements stayed closest to baseline and were lower than HAS and MC individually. Apart from objective measurements, perceived hydration was assessed by a subjective questionnaire. Volunteers who applied the routine reported greater immediate and long‐lasting hydration than those who applied HAS or MC individually. These results suggest that layering the Routine improved hydration durability with barrier‐relevant water‐retention benefits over an 8‐h wear period.
- Open Access
- 1 December 2025
- Published by KEAI Publishing in Journal of Dermatologic Science and Cosmetic Technology
- Vol. 2 (4)
A randomized trial evaluating an unmedicated acne-concealing hydrogel patch on the appearance of acne and its psychological impact on quality of life
- 1 December 2025
- Published by KEAI Publishing in Journal of Dermatologic Science and Cosmetic Technology
- Vol. 2 (4)
Open AccessA randomized trial evaluating an unmedicated acne-concealing hydrogel patch on the appearance of acne and its psychological impact on quality of life
- Open Access
- 26 August 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (8) , e0319891
A standardized scoring method for measuring white cast of mineral sunscreens and improving user compliance across diverse skin tones
Introduction: Using broad-spectrum sunscreen is an effective practice for preventing skin cancers caused by ultraviolet (UV) radiation. Mineral sunscreens containing zinc oxide (ZnO) and titanium dioxide (TiO2) as physical UV filters are suitable for individuals with sensitive skin or allergies to chemical UV filters. Consumer compliance with sunscreen application depends largely on its cosmetic elegance, especially regarding white cast. Despite this, there is no official method to quantify white cast and help design sunscreens for diverse skin tones. Methods: To address this gap, we developed white cast scoring protocols that combine 1) inter-rater reliability (ICC) of expert graders and thirteen study volunteers ranking the white cast produced by ZnO test formulations with 2) objective CIEL*a*b* measurements determined after sunscreen application both in vivo and in vitro. Results: Our findings demonstrate a significant correlation between increasing ZnO percentages and higher L* values (whiteness) resulting in a more visible white cast, as assessed by Pearson coefficient in vivo (r ≥ 0.822; p < 0.001) and Kruskal-Wallis (p < 0.0001) with Dunn’s post hoc pairwise comparisons. White cast scores for the ZnO formulations were substantially consistent across both in vivo and in vitro methodologies, with higher ZnO concentrations producing unacceptable levels of white cast. Conclusion: This study provides a white cast scoring system, based on subjective white cast perception and L* values, as a quantitative tool for evaluating and refining mineral sunscreen formulations, contributing to developing more cosmetically elegant sunscreens suitable for a wide range of skin tones.
- 26 August 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (8) , e0319891
Open AccessA standardized scoring method for measuring white cast of mineral sunscreens and improving user compliance across diverse skin tones
Introduction: Using broad-spectrum sunscreen is an effective practice for preventing skin cancers caused by ultraviolet (UV) radiation. Mineral sunscreens containing zinc oxide (ZnO) and titanium dioxide (TiO2) as physical UV filters are suitable for individuals with sensitive skin or allergies to chemical UV filters. Consumer compliance with sunscreen application depends largely on its cosmetic elegance, especially regarding white cast. Despite this, there is no official method to quantify white cast and help design sunscreens for diverse skin tones. Methods: To address this gap, we developed white cast scoring protocols that combine 1) inter-rater reliability (ICC) of expert graders and thirteen study volunteers ranking the white cast produced by ZnO test formulations with 2) objective CIEL*a*b* measurements determined after sunscreen application both in vivo and in vitro. Results: Our findings demonstrate a significant correlation between increasing ZnO percentages and higher L* values (whiteness) resulting in a more visible white cast, as assessed by Pearson coefficient in vivo (r ≥ 0.822; p < 0.001) and Kruskal-Wallis (p < 0.0001) with Dunn’s post hoc pairwise comparisons. White cast scores for the ZnO formulations were substantially consistent across both in vivo and in vitro methodologies, with higher ZnO concentrations producing unacceptable levels of white cast. Conclusion: This study provides a white cast scoring system, based on subjective white cast perception and L* values, as a quantitative tool for evaluating and refining mineral sunscreen formulations, contributing to developing more cosmetically elegant sunscreens suitable for a wide range of skin tones.
- Open Access
- 2 April 2025
- Published by MDPI AG in Preprints.org
Facial Toner Containing 2% Arbutin and 3% Niacinamide Improves Pore Appearance, Uneven Skin Texture, and Skin Brightness Measured by Individual Typology Angle
Facial skin appearance is a critical psychosocial component in today's consumer culture, leading to an increase in people taking care of their appearance by using skincare products. With various topical active ingredients in skincare, arbutin and niacinamide are among the safest and most effective for improving hyperpigmentation. This study assesses the efficacy of a Facial Toner containing 2% Arbutin and 3% Niacinamide, which was developed to improve the appearance of pores, uneven skin texture, and brightness. The test material was a Facial Toner containing 2% Arbutin and 3% Niacinamide. Volunteers with varying skin phototypes applied the toner twice daily for four weeks, and a dermatological clinical efficacy study was conducted. Efficacy was assessed subjectively by photographs and self-perception questionnaires and objectively by expert grading and CIEL*a*b* measurements. Expert grading demonstrated significant improvement in the appearance of pores, skin brightness, and uneven skin texture. Colorimetry measurements further support the improvement of facial skin tone and brightness after four weeks. Furthermore, these results demonstrated a significant increase in the Individual Typology Angle (ITA°) of 23% of volunteers, leading to a change in their skin color subtype. Additionally, volunteers noticed substantial improvements in smoothness (96.8%) while observing that their skin was looking more radiant (93.6%) and youthful (87.1%). Our Facial Toner containing 2% Arbutin and 3% Niacinamide improved the appearance of pores and uneven skin texture, demonstrating a noticeable enhancement in skin brightness and leaving users with a more radiant and youthful complexion.
- 2 April 2025
- Published by MDPI AG in Preprints.org
Open AccessFacial Toner Containing 2% Arbutin and 3% Niacinamide Improves Pore Appearance, Uneven Skin Texture, and Skin Brightness Measured by Individual Typology Angle
Facial skin appearance is a critical psychosocial component in today's consumer culture, leading to an increase in people taking care of their appearance by using skincare products. With various topical active ingredients in skincare, arbutin and niacinamide are among the safest and most effective for improving hyperpigmentation. This study assesses the efficacy of a Facial Toner containing 2% Arbutin and 3% Niacinamide, which was developed to improve the appearance of pores, uneven skin texture, and brightness. The test material was a Facial Toner containing 2% Arbutin and 3% Niacinamide. Volunteers with varying skin phototypes applied the toner twice daily for four weeks, and a dermatological clinical efficacy study was conducted. Efficacy was assessed subjectively by photographs and self-perception questionnaires and objectively by expert grading and CIEL*a*b* measurements. Expert grading demonstrated significant improvement in the appearance of pores, skin brightness, and uneven skin texture. Colorimetry measurements further support the improvement of facial skin tone and brightness after four weeks. Furthermore, these results demonstrated a significant increase in the Individual Typology Angle (ITA°) of 23% of volunteers, leading to a change in their skin color subtype. Additionally, volunteers noticed substantial improvements in smoothness (96.8%) while observing that their skin was looking more radiant (93.6%) and youthful (87.1%). Our Facial Toner containing 2% Arbutin and 3% Niacinamide improved the appearance of pores and uneven skin texture, demonstrating a noticeable enhancement in skin brightness and leaving users with a more radiant and youthful complexion.
- Open Access
A standard scoring method for measuring white cast of mineral sunscreens and improving user compliance across diverse skin tones
Using broad-spectrum sunscreen is an effective practice for preventing skin cancers caused by ultraviolet (UV) radiation. Mineral sunscreens containing zinc oxide (ZnO) and titanium dioxide (TiO 2 ) as physical UV filters are suitable for individuals with sensitive skin or allergies to chemical UV filters. Consumer compliance with sunscreen application depends largely on its cosmetic elegance, especially regarding white cast. Despite this, there is no official method to quantify white cast and help design sunscreens for diverse skin tones. To address this gap, we developed validated white cast scoring protocols that combine 1) subjective consumer feedback on formulations containing ZnO concentrations ranging from 0–30% with 2) objective L* measurements (whiteness) determined after sunscreen application. Our findings demonstrate a strong correlation between increasing ZnO percentages and higher L* values, resulting in a more visible white cast. White cast scores for the ZnO formulations were substantially consistent across both in vivo and in vitro methodologies, with higher ZnO concentrations producing unacceptable levels of white cast. This study provides a white cast scoring system as a quantitative tool for evaluating and refining mineral sunscreen formulations, contributing to the development of more cosmetically elegant sunscreens suitable for a wide range of skin tones.
Open AccessA standard scoring method for measuring white cast of mineral sunscreens and improving user compliance across diverse skin tones
Using broad-spectrum sunscreen is an effective practice for preventing skin cancers caused by ultraviolet (UV) radiation. Mineral sunscreens containing zinc oxide (ZnO) and titanium dioxide (TiO 2 ) as physical UV filters are suitable for individuals with sensitive skin or allergies to chemical UV filters. Consumer compliance with sunscreen application depends largely on its cosmetic elegance, especially regarding white cast. Despite this, there is no official method to quantify white cast and help design sunscreens for diverse skin tones. To address this gap, we developed validated white cast scoring protocols that combine 1) subjective consumer feedback on formulations containing ZnO concentrations ranging from 0–30% with 2) objective L* measurements (whiteness) determined after sunscreen application. Our findings demonstrate a strong correlation between increasing ZnO percentages and higher L* values, resulting in a more visible white cast. White cast scores for the ZnO formulations were substantially consistent across both in vivo and in vitro methodologies, with higher ZnO concentrations producing unacceptable levels of white cast. This study provides a white cast scoring system as a quantitative tool for evaluating and refining mineral sunscreen formulations, contributing to the development of more cosmetically elegant sunscreens suitable for a wide range of skin tones.
- Open Access
- 13 November 2021
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 185 (2) , 220-231
Chemical Exposure-Induced Developmental Neurotoxicity in Head-Regenerating Schmidtea mediterranea
The growing number of commercially used chemicals that are under-evaluated for developmental neurotoxicity (DNT) combined with the difficulty in describing the etiology of exposure-related neurodevelopmental toxicity has created a reticent threat to human health. Current means of screening chemicals for DNT are limited to expensive, time-consuming, and labor-intensive traditional laboratory animal models. In this study, we hypothesize that exposed head-regenerating planarian flatworms can effectively and efficiently categorize DNT in known developmental neurotoxins (ethanol and bisphenol A [BPA]). Planarian flatworms are an established alternative animal model for neurodevelopmental studies and have remarkable regenerative abilities allowing neurodevelopment to be induced via head resection. Here, we observed changes in photophobic behavior and central nervous system (CNS) morphology to evaluate the impact of exposure to low concentrations of ethanol, BPA, and BPA industry alternatives bisphenol F, and bisguaiacol on neurodevelopment. Our studies show that exposure to 1% v/v ethanol during regeneration induces a recoverable 48-h delay in the development of proper CNS integrity, which aligns with behavioral assessments of cognitive ability. Exposure to BPA and its alternatives induced deviations to neurodevelopment in a range of severities, distinguished by suppressions, delays, or a combination of the 2. These results suggest that quick and inexpensive behavioral assessments are a viable surrogate for tedious and costly immunostaining studies, equipping more utility and resolution to the planarian model for neurodevelopmental toxicity in the future of mass chemical screening. These studies demonstrate that behavioral phenotypes observed following chemical exposure are classifiable and also temporally correlated to the anatomical development of the CNS in planaria. This will facilitate and accelerate toxicological screening assays with this alternative animal model.
- 13 November 2021
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 185 (2) , 220-231
Open AccessChemical Exposure-Induced Developmental Neurotoxicity in Head-Regenerating Schmidtea mediterranea
The growing number of commercially used chemicals that are under-evaluated for developmental neurotoxicity (DNT) combined with the difficulty in describing the etiology of exposure-related neurodevelopmental toxicity has created a reticent threat to human health. Current means of screening chemicals for DNT are limited to expensive, time-consuming, and labor-intensive traditional laboratory animal models. In this study, we hypothesize that exposed head-regenerating planarian flatworms can effectively and efficiently categorize DNT in known developmental neurotoxins (ethanol and bisphenol A [BPA]). Planarian flatworms are an established alternative animal model for neurodevelopmental studies and have remarkable regenerative abilities allowing neurodevelopment to be induced via head resection. Here, we observed changes in photophobic behavior and central nervous system (CNS) morphology to evaluate the impact of exposure to low concentrations of ethanol, BPA, and BPA industry alternatives bisphenol F, and bisguaiacol on neurodevelopment. Our studies show that exposure to 1% v/v ethanol during regeneration induces a recoverable 48-h delay in the development of proper CNS integrity, which aligns with behavioral assessments of cognitive ability. Exposure to BPA and its alternatives induced deviations to neurodevelopment in a range of severities, distinguished by suppressions, delays, or a combination of the 2. These results suggest that quick and inexpensive behavioral assessments are a viable surrogate for tedious and costly immunostaining studies, equipping more utility and resolution to the planarian model for neurodevelopmental toxicity in the future of mass chemical screening. These studies demonstrate that behavioral phenotypes observed following chemical exposure are classifiable and also temporally correlated to the anatomical development of the CNS in planaria. This will facilitate and accelerate toxicological screening assays with this alternative animal model.
- 25 June 2020
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 20 (2) , 561-565
New topical tranexamic acid derivative for the improvement of hyperpigmentation and inflammation in the sun‐damaged skin
Background: Skin‐lightening products are used worldwide to treat persistent pigmentation disorders that impact our quality of life and self‐confidence. However, consumers of cosmetic and over‐the‐counter skin lighteners struggle to find products that perform to their expectations. New, safe, and effective bioactives are needed to fill this gap.Objective: To investigate the safety and skin‐lightening performance of a new topical tranexamic acid derivative, that is, cetyl tranexamate mesylate.Methods: The test material was a facial serum containing 2.0% (w/w) of the new bioactive. Safety was evaluated by a modified Human Repeat Insult Patch Test with 54 subjects of either sex. Performance was objectively assessed based on the improvement of melanin and erythema indexes through time, and also subjectively by photographs and self‐perception questionnaires. Thirty‐five female subjects applied the serum twice a day for 8 weeks.Results: No questionable adverse reactions were observed. Melanin and erythema indexes improved significantly and continuously from the baseline to the end of the study (−16.9% and −34.3%, respectively). Photographs further support instrumental data. On average, after 2 weeks, the subjects already noticed an improvement in skin tone (79.3%), a reduction in dark spots (78.6%), and an improvement in facial redness (77.1%).Conclusion: A topical serum containing cetyl tranexamate mesylate was well‐tolerated and successfully improved the overall facial skin tone, as well as the appearance of dark spots and redness.
- 25 June 2020
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 20 (2) , 561-565
New topical tranexamic acid derivative for the improvement of hyperpigmentation and inflammation in the sun‐damaged skin
Background: Skin‐lightening products are used worldwide to treat persistent pigmentation disorders that impact our quality of life and self‐confidence. However, consumers of cosmetic and over‐the‐counter skin lighteners struggle to find products that perform to their expectations. New, safe, and effective bioactives are needed to fill this gap.Objective: To investigate the safety and skin‐lightening performance of a new topical tranexamic acid derivative, that is, cetyl tranexamate mesylate.Methods: The test material was a facial serum containing 2.0% (w/w) of the new bioactive. Safety was evaluated by a modified Human Repeat Insult Patch Test with 54 subjects of either sex. Performance was objectively assessed based on the improvement of melanin and erythema indexes through time, and also subjectively by photographs and self‐perception questionnaires. Thirty‐five female subjects applied the serum twice a day for 8 weeks.Results: No questionable adverse reactions were observed. Melanin and erythema indexes improved significantly and continuously from the baseline to the end of the study (−16.9% and −34.3%, respectively). Photographs further support instrumental data. On average, after 2 weeks, the subjects already noticed an improvement in skin tone (79.3%), a reduction in dark spots (78.6%), and an improvement in facial redness (77.1%).Conclusion: A topical serum containing cetyl tranexamate mesylate was well‐tolerated and successfully improved the overall facial skin tone, as well as the appearance of dark spots and redness.